These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 8190331

  • 1. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ.
    Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
    [Abstract] [Full Text] [Related]

  • 2. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT.
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [Abstract] [Full Text] [Related]

  • 3. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Struijk DG, Dinkla C, Stolk LM, ten Berge IJ, Krediet RT.
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J, Klínger J, Arturo JA, Delgado M, Tobar C, Mosquera M.
    Adv Perit Dial; 2002 Aug; 18():177-83. PubMed ID: 12402614
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY.
    Adv Perit Dial; 1998 Aug; 14():173-9. PubMed ID: 10649719
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A, Hylander B, Wretlind B.
    Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
    Sach M, Loetscher P, Burger JA, Knopf HP, Schollmeyer P, Dobos GJ.
    Adv Perit Dial; 1995 Sep; 11():19-23. PubMed ID: 8534702
    [Abstract] [Full Text] [Related]

  • 10. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D, Colić M, Stanković-Popović V, Radojević M, Bokonjić D.
    Med Pregl; 2007 Sep; 60 Suppl 2():53-7. PubMed ID: 18928158
    [Abstract] [Full Text] [Related]

  • 11. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis.
    Betjes MG, Visser CE, Zemel D, Tuk CW, Struijk DG, Krediet RT, Arisz L, Beelen RH.
    Perit Dial Int; 1996 Sep; 16(4):385-92. PubMed ID: 8863332
    [Abstract] [Full Text] [Related]

  • 12. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S.
    Adv Perit Dial; 1997 Sep; 13():7-12. PubMed ID: 9360642
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY, Huang TP.
    Adv Perit Dial; 1990 Sep; 6():114-9. PubMed ID: 1982786
    [Abstract] [Full Text] [Related]

  • 15. Impaired initial cell reaction in CAPD-related peritonitis.
    Koopmans JG, Boeschoten EW, Pannekeet MM, Betjes MG, Zemel D, Kuijper EJ, Krediet RT.
    Perit Dial Int; 1996 Sep; 16 Suppl 1():S362-7. PubMed ID: 8728224
    [Abstract] [Full Text] [Related]

  • 16. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D, Vasilijic S, Colic M, Stankovic-Popovic V, Bokonjic D.
    Adv Perit Dial; 2009 Sep; 25():50-5. PubMed ID: 19886317
    [Abstract] [Full Text] [Related]

  • 17. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT.
    Perit Dial Int; 1995 Sep; 15(2):134-41. PubMed ID: 7612733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH, Lin CY.
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [Abstract] [Full Text] [Related]

  • 20. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.